GO:0102320 1,8-cineole 2-exo-monooxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0102320 describes the monooxygenase activity that converts 1,8-cineole to 2-exo-hydroxy-1,8-cineole using NADPH and O2.
• The reaction is a cytochrome P450-type monooxygenation, mechanistically related to well-characterized CYP3A4 and CYP2E1 oxidations.
• CYP3A4 is the best-studied human P450 model for this class of chemistry, with structures and anion-dependent stimulation well documented.
• CYP2E1 and CYP3A4 activities are modified in haemoglobin E-beta thalassemia patients, showing disease-linked regulation of P450 monooxygenases.
• Nitric oxide can modulate CYP2D6 and CYP3A4 activity via heme loading, revealing post-translational control of P450 catalysis.
• Thiomers and statins can inhibit cytochrome P450 activity, which is relevant for drug interaction and toxicity studies.
Description
GO:0102320, 1,8-cineole 2-exo-monooxygenase activity, is a molecular function defined by the catalytic conversion of 1,8-cineole to 2-exo-hydroxy-1,8-cineole in the presence of NADPH, H+ and O2, yielding NADP and H2O. This activity belongs to the broad class of cytochrome P450 monooxygenases that activate molecular oxygen and insert one oxygen atom into an organic substrate. Understanding this term is important because 1,8-cineole is a widely occurring monoterpene and its oxidative metabolism exemplifies how P450 enzymes process small lipophilic molecules. Researchers studying this activity can leverage decades of structural and mechanistic work on human P450s such as CYP3A4 and CYP2E1 to design experiments and interpret results. The term is therefore a useful entry point for linking monoterpene biochemistry to P450 enzymology, drug metabolism and disease-associated changes in monooxygenase activity.
1,8-cineole 2-exo-monooxygenase activity At A Glance
| GO ID | GO:0102320 |
|---|---|
| GO term | 1,8-cineole 2-exo-monooxygenase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of 1,8-cineole + NADPH + H+ + O2 = 2-exo-hydroxy-1,8-cineole + NADP + H2O |
| Reaction type | Monooxygenation (one oxygen atom incorporated into substrate) |
| Cofactor requirement | NADPH and molecular oxygen |
| Representative enzyme class | Cytochrome P450 monooxygenase |
| Related human P450s | CYP3A4, CYP2E1, CYP2D6 (mechanistic and regulatory models) |
What Is GO:0102320?
In simple terms, GO:0102320 is the enzyme activity that adds one oxygen atom to 1,8-cineole, producing 2-exo-hydroxy-1,8-cineole. The official definition states: Catalysis of the reaction: 1,8-cineole + NADPH + H+ + O2 = 2-exo-hydroxy-1,8-cineole + NADP + H2O. This is a monooxygenase reaction because only one atom of molecular oxygen is incorporated into the substrate, while the other is reduced to water. The activity requires NADPH as the electron donor and a heme-containing P450 active site for oxygen activation, similar to other cytochrome P450 monooxygenations.
Why Is 1,8-cineole 2-exo-monooxygenase activity Important in Cell Biology?
GO:0102320 matters because it captures a specific P450-mediated oxidation of a monoterpene, and the same mechanistic principles govern many human P450 reactions that determine drug metabolism, hormone synthesis and toxicity. The activity is a model for understanding how cytochrome P450 enzymes achieve regio- and stereo-selective hydroxylation of small lipophilic substrates. Because P450 activities can be altered in disease and by inhibitors, studying this term helps connect monoterpene biochemistry to clinically relevant changes in monooxygenase function.
• Defines a specific P450 monooxygenation reaction that converts 1,8-cineole to 2-exo-hydroxy-1,8-cineole.
• Provides a mechanistic model for cytochrome P450-catalyzed hydroxylation of small lipophilic molecules.
• Links monoterpene metabolism to the broader family of human P450 enzymes such as CYP3A4 and CYP2E1.
• Helps interpret disease-associated changes in P450 activity, as seen in haemoglobin E-beta thalassemia patients.
• Supports studies of P450 inhibition by xenobiotics such as thiomers, relevant to drug interaction screening.
• Connects to statin-related myotoxicity, where P450-mediated metabolism influences drug exposure and toxicity.
• Highlights post-translational regulation of P450 activity by nitric oxide via heme loading.
• Offers a framework for studying heterotropic cooperativity in P450 oxidation.
• Relevant to vitamin D metabolism, which is carried out by multiple cytochrome P450s.
• Guides experimental design for enzyme assays, inhibitor testing and metabolic profiling.
Molecular Mechanism of 1,8-cineole 2-exo-monooxygenase activity
Substrate binding and active-site recognition
In simple terms: The enzyme first grabs 1,8-cineole and holds it in the right position.
The reaction begins when 1,8-cineole binds in the active site of a cytochrome P450-type monooxygenase, positioning the substrate for regio- and stereo-selective oxidation. Structural studies of CYP3A4 show that P450 active sites can accommodate small lipophilic substrates and orient them for hydroxylation. Heterotropic cooperativity in P450 oxidation indicates that substrate binding can be modulated by additional ligands, which is relevant for predicting how 1,8-cineole is processed.
Oxygen activation and NADPH-dependent electron transfer
In simple terms: The enzyme uses NADPH and oxygen to create a reactive oxygen species that attacks the substrate.
After substrate binding, the P450 heme iron is reduced and molecular oxygen is activated, with NADPH supplying electrons. Anion-dependent stimulation of CYP3A4 monooxygenase activity shows that the electron transfer steps can be influenced by the ionic environment. This oxygen activation step is the chemical core of GO:0102320, because it enables insertion of one oxygen atom into 1,8-cineole while the other is reduced to water.
Regio- and stereo-selective hydroxylation
In simple terms: The enzyme adds an oxygen atom at a specific position, making 2-exo-hydroxy-1,8-cineole.
The defining outcome of GO:0102320 is the formation of 2-exo-hydroxy-1,8-cineole, which requires precise control of the site of oxidation. Cytochrome P450 enzymes are known for their ability to perform selective oxidations, as illustrated by CYP3A4 and related P450s. This selectivity is central to the biological and biotechnological relevance of the activity, because different hydroxylation products can have distinct properties.
Cofactor requirements and product release
In simple terms: NADPH is consumed, and the products are released.
The reaction consumes NADPH and O2 and produces 2-exo-hydroxy-1,8-cineole, NADP and H2O. P450 monooxygenases depend on NADPH-cytochrome P450 reductase or related redox partners to deliver electrons, as established for human P450 systems. After hydroxylation, the product leaves the active site, allowing the enzyme to cycle again.
Regulation by heme loading and inhibitors
In simple terms: The enzyme's activity can go up or down depending on heme availability and inhibitory molecules.
Nitric oxide regulates CYP2D6 and CYP3A4 activity via concentration-dependent modulation of heme loading, showing that heme availability controls P450 catalysis. Inhibitors such as thiomers can suppress cytochrome P450 activity, which is relevant for predicting interactions with 1,8-cineole oxidation. Disease states can also modify P450 activities, as observed for CYP2E1 and CYP3A4 in haemoglobin E-beta thalassemia patients.
Key Genes Involved in GO:0102320 1,8-cineole 2-exo-monooxygenase activity
The following genes and proteins are mechanistically or clinically relevant to cytochrome P450 monooxygenase activities of the type represented by GO:0102320.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP3A4 | Major human P450 monooxygenase; structurally well characterized | Model enzyme for P450-catalyzed hydroxylation and anion-dependent stimulation |
| CYP2E1 | Human P450 involved in small-molecule oxidation | Activity modified in haemoglobin E-beta thalassemia patients |
| CYP2D6 | Human P450 with heme-dependent activity | Regulated by nitric oxide via heme loading |
| CYP24A1 | Cytochrome P450 involved in vitamin D metabolism | Example of P450-mediated oxidation of small lipophilic substrates |
| CYP27B1 | Cytochrome P450 involved in vitamin D metabolism | Illustrates diversity of P450 monooxygenation reactions |
| CYP2R1 | Cytochrome P450 involved in vitamin D metabolism | Shows P450s catalyze related hydroxylation chemistry |
| CYP3A5 | P450 family member with overlapping substrate specificity | Relevant to comparative P450 enzymology |
| CYP3A7 | Fetal P450 family member | Provides evolutionary and developmental context for P450 activity |
| CYP1A2 | P450 involved in xenobiotic oxidation | General P450 model for monooxygenase assays |
| CYP2C9 | P450 with clinically important drug substrates | Relevant to inhibitor and drug interaction studies |
| CYP2C19 | P450 with polymorphic activity | Context for inter-individual variation in P450 activity |
| CYP2B6 | P450 involved in drug and xenobiotic metabolism | Model for heterotropic cooperativity studies |
| CYP4A11 | Fatty acid omega-hydroxylase P450 | Example of P450 substrate diversity |
| CYP7A1 | P450 in bile acid synthesis | Illustrates physiological roles of P450 monooxygenases |
| CYP11A1 | P450 in steroidogenesis | Shows P450s act on diverse lipophilic substrates |
| CYP17A1 | P450 in steroid hormone synthesis | Relevant to endocrine P450 biology |
| CYP21A2 | P450 in steroid metabolism | Context for P450-related disease models |
How Is 1,8-cineole 2-exo-monooxygenase activity Regulated?
The activity class represented by GO:0102320 is regulated at multiple levels. Nitric oxide can modulate CYP2D6 and CYP3A4 activity through concentration-dependent effects on heme loading, indicating that heme availability is a key regulatory node. Inhibitors such as thiomers can directly suppress cytochrome P450 activity, providing a pharmacological layer of regulation. Disease states can also alter P450 activity, as shown by modified CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. In addition, heterotropic cooperativity can change how P450 enzymes respond to substrates and effectors, which may influence the rate of 1,8-cineole oxidation.
1,8-cineole 2-exo-monooxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP3A4 | Statin-related myotoxicity and drug metabolism | Hepatocyte knockout or knock-in of CYP3A4 variants |
| CYP2E1 | Haemoglobin E-beta thalassemia-associated P450 changes | Patient-derived cells or isogenic point-mutation models |
| CYP2D6 | Nitric oxide-mediated regulation of P450 activity | Heme-loading reporter and knockout cell lines |
| CYP24A1 | Vitamin D metabolism disorders | Knockout and overexpression models for P450 hydroxylation |
| CYP2C9 | Drug interaction and toxicity risk | Inhibitor screening in P450-expressing cell models |
Statin-related myotoxicity and P450 metabolism
Statin-related myotoxicity is influenced by cytochrome P450-mediated drug metabolism, and understanding P450 activities such as those represented by GO:0102320 helps explain inter-individual differences in drug exposure and toxicity. Because statins and other drugs can interact with P450 enzymes, changes in monooxygenase activity may affect clinical outcomes.
Haemoglobin E-beta thalassemia and altered P450 activity
CYP2E1 and CYP3A4 activities are modified in haemoglobin E-beta thalassemia patients, demonstrating that disease states can alter P450 monooxygenase function. This has implications for how patients metabolize substrates related to 1,8-cineole and other P450-dependent compounds.
Nitric oxide and heme-dependent regulation in disease
Nitric oxide regulates CYP2D6 and CYP3A4 activity via concentration-dependent modulation of heme loading, linking inflammatory or oxidative stress conditions to changes in P450 catalysis. Such regulation could affect the metabolism of monoterpenes and other P450 substrates in disease settings.
From 1,8-cineole 2-exo-monooxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate P450 abolish 1,8-cineole 2-exo-monooxygenase activity? | CRISPR knockout of the candidate P450 gene |
| Does a specific amino acid change alter substrate selectivity? | Point-mutation knock-in of the catalytic residue |
| Can a tagged P450 be used to measure expression and localization? | Tagged knock-in at the endogenous locus |
| Does overexpression increase 2-exo-hydroxy-1,8-cineole production? | Overexpression cell model |
| Which P450 genes contribute to monoterpene oxidation? | CRISPR library screening |
| How does disease-associated heme loading affect P450 activity? | Knockout plus heme-loading modulation |
How to Study the 1,8-cineole 2-exo-monooxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADPH consumption assay | Monooxygenase electron transfer | Detecting P450 activity |
| LC-MS product detection | Formation of 2-exo-hydroxy-1,8-cineole | Confirming GO:0102320 activity |
| Inhibitor titration | Sensitivity to P450 inhibitors | Drug interaction screening |
| Heme loading assay | Post-translational regulation of P450 | Nitric oxide modulation studies |
| Patient-derived cell assay | Disease-associated P450 activity changes | Thalassemia-related P450 studies |
| Structural modeling | Active-site substrate positioning | Mechanistic interpretation of P450 selectivity |
| Cooperativity analysis | Effector effects on P450 kinetics | Heterotropic cooperativity studies |
| Vitamin D P450 profiling | Related P450 hydroxylation reactions | Comparative P450 enzymology |
Enzyme activity assays
Monooxygenase activity can be measured by monitoring NADPH consumption or product formation, as established for cytochrome P450 enzymes. For GO:0102320, assays would detect 2-exo-hydroxy-1,8-cineole formation from 1,8-cineole. Anion-dependent stimulation of CYP3A4 monooxygenase activity illustrates how buffer conditions can be optimized in such assays.
Inhibitor and drug interaction profiling
Thiomers inhibit cytochrome P450 activity, providing a template for testing whether candidate inhibitors block 1,8-cineole oxidation. Statin-related myotoxicity studies highlight the clinical importance of P450 inhibition and metabolism. Such profiling can identify compounds that modulate P450-dependent monoterpene oxidation.
Heme loading and regulatory studies
Nitric oxide regulates CYP2D6 and CYP3A4 activity via concentration-dependent modulation of heme loading, offering a method to study post-translational control of P450 activity. Disease-associated changes in P450 activity, as seen in haemoglobin E-beta thalassemia, can be modeled in patient-derived cells. These approaches help determine whether 1,8-cineole 2-exo-monooxygenase activity is altered under stress or disease conditions.
Structural and computational analysis
Structures of cytochrome P450 3A4 provide a framework for modeling substrate binding and oxygen activation in related P450 reactions. Heterotropic cooperativity studies inform computational predictions of how effectors influence P450 oxidation. These methods support hypothesis generation for GO:0102320 without requiring direct structural data for the specific enzyme.
How CRISPR Can Be Used to Study GO:0102320 1,8-cineole 2-exo-monooxygenase activity
Knockout
CRISPR knockout of candidate P450 genes can test whether a specific enzyme is required for 1,8-cineole 2-exo-monooxygenase activity. Loss-of-function models are useful for distinguishing essential P450s from redundant family members, as suggested by the diversity of P450 enzymes.
Point Mutation
Point-mutation knock-in can alter catalytic residues or heme-binding motifs to test their role in monooxygenation. Such models help dissect the mechanism of oxygen activation and substrate selectivity in P450 enzymes.
Knock-in
Tagged knock-in at the endogenous locus enables tracking of P450 expression and localization without overexpression artifacts. This is valuable for studying how disease-associated changes affect P450 activity.
Overexpression
Overexpression of a candidate P450 can increase production of 2-exo-hydroxy-1,8-cineole and facilitate biochemical characterization. Overexpression models are also useful for inhibitor testing and drug interaction studies.
How EDITGENE Supports 1,8-cineole 2-exo-monooxygenase activity Research
Researchers studying 1,8-cineole 2-exo-monooxygenase activity-related genes often need to determine whether a candidate gene is causally involved in the reaction, how specific mutations alter catalysis, and whether expression changes affect product formation. EDITGENE provides CRISPR-based cell models and screening services to address these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for 1,8-cineole 2-exo-monooxygenase activity research.
Frequently Asked Questions About 1,8-cineole 2-exo-monooxygenase activity
What is 1,8-cineole 2-exo-monooxygenase activity?
It is the enzyme activity defined by GO:0102320 that converts 1,8-cineole to 2-exo-hydroxy-1,8-cineole using NADPH and O2.
What is the GO ID for 1,8-cineole 2-exo-monooxygenase activity?
The GO ID is GO:0102320, under the molecular_function ontology.
What reaction does GO:0102320 catalyze?
It catalyzes 1,8-cineole + NADPH + H+ + O2 = 2-exo-hydroxy-1,8-cineole + NADP + H2O.
What genes are involved in 1,8-cineole 2-exo-monooxygenase activity?
Cytochrome P450 genes such as CYP3A4, CYP2E1 and CYP2D6 are mechanistically and clinically relevant models for this activity class.
Which enzyme class carries out this activity?
The activity is characteristic of cytochrome P450 monooxygenases, which activate oxygen and insert one atom into substrates.
How is this activity regulated?
It can be regulated by heme loading, as shown for CYP2D6 and CYP3A4, and by inhibitors such as thiomers.
Is this activity relevant to human disease?
Yes, P450 activities are altered in conditions such as haemoglobin E-beta thalassemia and influence statin-related myotoxicity.
What methods are used to study GO:0102320?
NADPH consumption assays, LC-MS product detection, inhibitor titration and heme loading assays are commonly used.
Can CRISPR be used to study this activity?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models can test the role of candidate P450 genes.
What is the synonym for GO:0102320?
There are no synonyms listed for GO:0102320 in QuickGO.
Conclusion
GO:0102320, 1,8-cineole 2-exo-monooxygenase activity, represents a specific cytochrome P450-type monooxygenation that converts 1,8-cineole to 2-exo-hydroxy-1,8-cineole. Its study benefits from extensive mechanistic and clinical knowledge of human P450 enzymes such as CYP3A4, CYP2E1 and CYP2D6, including their regulation by heme loading and inhibitors. Researchers can use CRISPR-based models to dissect the genetic and biochemical basis of this activity and its relevance to drug metabolism and disease.
References
- 1. Fernandes V et al.. 2016. Statin-related myotoxicity.. Endocrinol Nutr 63(5):239-49 PMID: 27005745
- 2. Scott EE et al.. 2005. Structures of cytochrome P450 3A4.. Trends Biochem Sci 30(1):5-7 PMID: 15653318
- 3. Ohyama Y et al.. 2004. Eight cytochrome P450s catalyze vitamin D metabolism.. Front Biosci 9:3007-18 PMID: 15353333
- 4. Sevrioukova IF et al.. 2015. Anion-Dependent Stimulation of CYP3A4 Monooxygenase.. Biochemistry 54(26):4083-96 PMID: 26066995
- 5. Niwa T et al.. 2008. Heterotropic cooperativity in oxidation mediated by cytochrome p450.. Curr Drug Metab 9(5):453-62 PMID: 18537580
- 6. Somparn N et al.. 2007. Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients.. Eur J Clin Pharmacol 63(1):43-50 PMID: 17119944
- 7. Das Sinha P et al.. 2025. Nitric oxide regulates cytochrome P450 2D6 and 3A4 activity via concentration-dependent modulation of heme loading.. J Biol Chem 301(11):110772 PMID: 41022321
- 8. Iqbal J et al.. 2011. Thiomers: Inhibition of cytochrome P450 activity.. Eur J Pharm Biopharm 78(3):361-5 PMID: 21362475
